Novonorm

Basic NovoNorm information

• INN (international nonproprietary name): Repaglinide
• Brand names available in the United Kingdom: NovoNorm; generic repaglinide
• ATC code: A10BX02
• Forms and dosages: Tablets 0.5 mg, 1 mg, 2 mg
• Manufacturers in the United Kingdom: Novo Nordisk (NovoNorm) and generic manufacturers
• Registration status in the United Kingdom: Prescription-only medicine (POM)
• OTC / Rx classification: Prescription-only medicine (POM)

Morning vs evening dosing

NovoNorm is taken shortly before main meals, generally within a 30-minute window. This allows the medication to work in tandem with food intake.

NovoNorm is taken with each main meal, so the timing of the doses follows your usual mealtimes, for example before breakfast, lunch and dinner.

Keeping the doses linked to regular mealtimes can lead to better adherence and improved glucose control.

Taking with or without meals

Meal timing is essential when taking NovoNorm. Take each dose shortly before a main meal. If you skip a meal, skip the dose for that meal; if you add an extra meal, take an extra dose as directed by your prescriber.

Safety priorities

Who should avoid it (MHRA warnings)

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued guidelines on who should avoid NovoNorm. NovoNorm is not recommended for children because of insufficient safety and efficacy data. It must not be used in type 1 diabetes or diabetic ketoacidosis, in severe liver impairment, or together with gemfibrozil.

Activities to limit (driving, work safety)

Engaging in activities such as driving or operating heavy machinery may pose risks for individuals taking NovoNorm. Hypoglycaemia, a potential side effect of this medication, can lead to dizziness, confusion, or fainting, which significantly impacts one's ability to safely perform these tasks. It's crucial to monitor blood sugar levels regularly, especially during the initial phases of treatment or after adjustments have been made to the dosage. Awareness and proactive management can help prevent accidents related to low blood sugar.

Dosage and adjustments

General regimen (NHS guidance)

For adults, the initial dose is generally 0.5 mg if HbA1c is below 8%. For those with higher HbA1c levels (8% or above), a starting dose of 1 mg is recommended. The dose is taken shortly before each main meal and adjusted by the prescriber, usually at intervals of one to two weeks. Regular monitoring and communication with healthcare providers will help patients maintain their prescribed regimen.

Special cases (elderly, comorbidities)

Dosage adjustments may be necessary for elderly patients or individuals with comorbidities. A lower starting dose of 0.5 mg may be prudent for the elderly, especially if renal impairment is present. Continuous monitoring is essential in these cases to avoid adverse effects.

What’s inside and how it works

Ingredients overview

Each tablet of NovoNorm contains the active ingredient repaglinide, which belongs to the meglitinide class of diabetes medications.

The tablets also contain inactive excipients; check the patient information leaflet if you have allergies or sensitivities.

Mechanism basics explained simply

Repaglinide stimulates insulin secretion from the pancreas, timed around meal consumption. By increasing insulin levels just as food is being digested, repaglinide helps to lower blood glucose levels effectively.

In type 2 diabetes, this mechanism mainly addresses post-meal glucose spikes.

Main indications

Approved uses (MHRA listing)

In the UK, NovoNorm is licensed for the management of type 2 diabetes mellitus in adults whose blood glucose cannot be controlled by diet, weight reduction and exercise alone. It can also be used in combination with metformin.

Off-label uses in UK clinics

Any use outside the licensed indication should only take place under the supervision of a healthcare professional.

Interaction warnings

Food interactions (alcohol)

Alcohol can increase or prolong the blood-glucose-lowering effect of NovoNorm and raises the risk of hypoglycaemia. It is advisable to limit or avoid alcohol while taking this medication.

Drug conflicts

NovoNorm must not be taken with gemfibrozil, and clopidogrel and ciclosporin also interact with it. Other diabetes medicines can add to the risk of hypoglycaemia. Tell your healthcare provider about all the medicines you take, and report suspected side effects through the Yellow Card scheme.

Alternative choices

Alternatives to NovoNorm that may be considered include:

• Metformin
  • Pros: Well-researched, offers additional benefits like weight loss; generally well-tolerated.
  • Cons: Gastrointestinal side effects may deter some patients; not suitable for individuals with renal impairment.
• Sulfonylureas (e.g. glipizide)
  • Pros: Effective at lowering blood sugar; well-studied over decades.
  • Cons: Risk of hypoglycaemia; potential weight gain in some patients.
• DPP-4 inhibitors (e.g. sitagliptin)
  • Pros: Weight-neutral, low risk of hypoglycaemia, can be taken once daily.
  • Cons: May lead to gastrointestinal issues.

The choice of medicine should take account of patient preferences and potential side effects.

Regulation snapshot

NovoNorm is a prescription-only medicine (POM) licensed in the UK by the Medicines and Healthcare products Regulatory Agency (MHRA).

NHS prescribing frameworks and NICE clinical guidelines guide healthcare professionals in using NovoNorm for patients with type 2 diabetes.

Frequently asked questions

What is NovoNorm used for?

It is prescribed to manage blood glucose levels in adults with type 2 diabetes, primarily addressing spikes that occur after meals.

Can I take NovoNorm if I skip a meal?

If a meal is skipped, it is advisable to skip the dose of NovoNorm for that meal and continue with the next scheduled dose.

What should I do if I miss a dose?

Simply resume your normal dosing schedule with the next meal; do not double the next dose.

Are there any common side effects of NovoNorm?

The most common side effects include hypoglycaemia, abdominal pain and diarrhoea. Monitoring is crucial for those prone to low blood sugar.

Is NovoNorm available without a prescription?

No – in the UK NovoNorm is a prescription-only medicine.

Guidelines for proper use

UK pharmacist counselling style

Pharmacists can guide patients on the correct use of NovoNorm, including dosage timing, logging blood sugar levels and potential side effects. They may also provide practical support materials such as:

• Information leaflets detailing drug interactions.
• Dosing calendars to optimise medication schedules.

NHS patient support advice

Several national resources are available for patients to seek further guidance in managing diabetes, including:

• The NHS Diabetes website, offering comprehensive education and community support.
• Patient helplines accessible for personalised assistance.